XPERT MTB/RIF TEST FOR THE DIAGNOSIS OF TUBERCULOSIS AND RIFAMPICIN RESISTANCE: RESULTS OF ITS INTRODUCTION IN THE KYRGYZ REPUBLIC
Abstract
About the Authors
A. D. AdambekovaKyrgyzstan
г. Бишкек
D. A. Adambekov
Kyrgyzstan
г. Бишкек
V. I. Litvinov
Russian Federation
г. Москва
References
1. Исакова Ж. Т. Молекулярно-эпидемиологический анализ рифампицин- и изониазид-устойчивых штаммов M. tuberculosis, циркулирующих в Кыргызской Республике // Респиратор. медицина. – 2008. – № 1. – C. 63-66.
2. Мырзалиев Б. Б., Алишеров А. Ш., Курманов Р. А. Проблемы лекарственной резистентности // Журн. теорет. и клин. мед. – 2005. – № 2. – С. 85-89.
3. Руководство по борьбе с туберкулезом в Кыргызской Республике / Под ред. А. Ш. Алишерова. – 2008.
4. Blakemore R., Story E., Helb D. et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay // J. Clin. Microbiol. – 2010. – Vol. 48, № 7. – Р. 2495-2501.
5. Boehme C. C., Nabeta P., Hillemann D. et al. Rapid molecular detection of tuberculosis and rifampin resistance // N. Engl. J. Med. – 2010. – Vol. 363, № 11. – Р. 1005-1015.
6. Boehme C. C., Nicol M. P., Nabeta P. Feasibility and impact of decentralized use of Xpert MTB/RIF for the diagnosis of tuberculosis and multi-drug resistance –results from a multi-center imple-mentation study // Lancet. – 2011. – Vol. 377. – Р. 1495-1505.
7. Cepheid. Brochure: Xpert®MTB/RIF. Two-hour detection of MTB and resistance to rifampicin. http://www.cepheid.com/media/files/eu/brochures/ Xpert MTB Broch R9 EU.pdf. Sunnyvale, Accessed 17, June 2012.
8. Chaisson R. E., Nuermberger E. L. Confronting multidrug-resistant tuberculosis // N. Engl. J. Med. – 2012. – Vol. 366, № 23. – Р. 2223-2224.
9. Helb D., Jones M., Story E. et al. Rapid detection of M. tuberculosis and rifampin resistance by use of on-demand, near-patient technology // J. Clin. Microbiol. – 2010. – Vol. 48, № 1. – Р. 229-237.
10. Hillemann D., Rusch-Gerdes S., Boehme C.et al. Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system // J. Clin. Microbiol. – 2011. – Vol. 49. – Р. 1202-1205.
11. Marlowe E. M., Novak-Weekley S. M., Cumpio J. Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens // J. Clin. Microbiol. – Vol. 49. – Р. 1621-1623.
12. Rapid implementation of the Xpert MTB/RIF diagnostic test: technical and operational «How-to»; practical considerations. WHO. 2011.
13. Rapid implementation of the Xpert MTB/RIF diagnostic test. Technical and operational «How-to». Practical considerations. WHO/HTM/TB/2011.2. Geneva: World Health Organization, 2011.
14. Review of the laboratory network of the Kyrgyz Republic. 9-29 April 2012. Dr. Harald Hoffmann & Dr. Uladzimir Antonenka, TB Laboratory Experts, IML red GmbH, Germany.
15. World Health Organization. Global tuberculosis control: WHO report 2011. WHO/HTM/TB/2011.16. World Health Organization, Geneva, Switzerland, 2011.
16. WHO (World Health Organisation). Global tuberculosis control-epidemiology, strategy, financing. Geneva, WHO, 2009 (WHO/HTM/TB/2009.411). World Health Organization.
17. Xpert® MTB/RIF implementation in MSF field projects. Martina Casenghi, Elisa Ardizzoni. 5th GLI meeting.16 April, 2013.
18. Zignol M., van Gemert W., Falzon D. et al. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010.Bulletin of the World Health Organization 2012; 90 (2).
Review
For citations:
Adambekova A.D., Adambekov D.A., Litvinov V.I. XPERT MTB/RIF TEST FOR THE DIAGNOSIS OF TUBERCULOSIS AND RIFAMPICIN RESISTANCE: RESULTS OF ITS INTRODUCTION IN THE KYRGYZ REPUBLIC. Tuberculosis and Lung Diseases. 2014;(1):34-36. (In Russ.)